Literature DB >> 2228307

Occurrence of non-gastric cancer in the digestive tract after remote partial gastrectomy: analysis of an Amsterdam cohort.

A C Tersmette1, G J Offerhaus, F M Giardiello, K W Tersmette, J P Vandenbroucke, G N Tytgat.   

Abstract

If peptic ulcer surgery favors the formation of carcinogenic N-nitroso compounds in the gastric remnant, an increased risk of cancer at sites in the gastrointestinal tract distant from the stomach might be predicted. To estimate the risk of carcinomas in the digestive tract, other than the stomach, occurring after partial gastrectomy, we analyzed an Amsterdam cohort of 2,633 post-gastrectomy patients operated on for benign disease between 1931 and 1960. Mortality in the study population was compared with the general Dutch population through person-year analysis. An excess mortality of biliary tract cancer (O/E:2.64; CL:1.32-4.72; p less than 0.01) and pancreatic cancer (O/E:1.65; CL:1.06-2.44; p less than 0.05) was found in males more than 5 years after surgery; females showed only an increased risk of pancreatic cancer in the first 5 years postoperatively (O/E:15.33; CL:1.85-55.43; p less than 0.01), probably due to misdiagnosis. All other non-gastric sites of the digestive tract carried no increased risk for cancer. In males, mortality due to colorectal cancer more than 5 years post-operatively was significantly decreased (O/E:0.58; CL 0.34-0.92; p less than 0.01). The excess mortality of biliary-tract and pancreatic cancer in males, which increases with the duration of post-operative interval, is consistent with a dose-response phenomenon. This study therefore supports the hypothesis that carcinogens are not only locally activated in the gastric remnant, but are hepatically excreted and initiate cancer in the biliary tree and pancreatic duct. Further exploration of this mechanism of carcinogenesis is warranted, since it may also explain the pathogenesis of pancreatic and biliary cancers in patients without gastrectomy.

Entities:  

Mesh:

Year:  1990        PMID: 2228307     DOI: 10.1002/ijc.2910460507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Gastrectomy and subsequent risk of oesophageal cancer in Milan.

Authors:  C La Vecchia; B D'Avanzo; E Negri; S Franceschi; P Boyle
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

3.  Mortality among patients with partial gastrectomy for benign ulcer disease.

Authors:  G Lundegårdh; C Helmick; M Zack; H O Adami
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

4.  History of peptic ulcer disease and pancreatic cancer risk in men.

Authors:  Ying Bao; Donna Spiegelman; Ruifeng Li; Edward Giovannucci; Charles S Fuchs; Dominique S Michaud
Journal:  Gastroenterology       Date:  2009-10-07       Impact factor: 22.682

5.  Seropositivity to Helicobacter pylori and risk of pancreatic cancer.

Authors:  Guoqin Yu; Gwen Murphy; Angelika Michel; Stephanie J Weinstein; Satu Männistö; Demetrius Albanes; Michael Pawlita; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

6.  Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.

Authors:  Adeyinka O Laiyemo; Farin Kamangar; Pamela M Marcus; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol       Date:  2009-10-01       Impact factor: 2.984

7.  Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Authors:  M C Bradley; L J Murray; M M Cantwell; C M Hughes
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

8.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.

Authors:  D T Silverman; M Schiffman; J Everhart; A Goldstein; K D Lillemoe; G M Swanson; A G Schwartz; L M Brown; R S Greenberg; J B Schoenberg; L M Pottern; R N Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Second primary cancer after diagnosis of stomach cancer in Osaka, Japan.

Authors:  T Hiyama; A Hanai; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1991-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.